I keep thinking back to Pharmasset, and their $5.5 billion market cap. They have 2 drug candidates in Phase 2, one in Phase 1 one and one in pre-clinical research.
Next year, Benitec, all going well, will have the HBV in Phase 1, the pain therapeutic in Phase 1. Possibly NSLC in Phase 1, muscular dytrophy in pre-clinical. Indirectly they will have Calimmune in Phase 2, City of Hope in Phase 1/2, Gradalis in Phase 1, retinitis pigmentosis in Phase 1. They may well even have a collaborator for their own HIV/AIDS trial. The HCV drug, via Tacere/Pfizer, may still bear fruit. Licence Agreements need to be paid sometime and I expect there will be some pressure of these companies to pay up.
All for a lousy $14 million, with over $5 million cash.
IMO there is no need to panic.
- Forums
- ASX - By Stock
- BLT
- i am now gobsmacked! wth is going on?
i am now gobsmacked! wth is going on?, page-19
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online